Please login or register first to view this content.
Psychiatric Disorders Resource Center
Drug Monographs
Click on the subsection below to see prescribing information
NEWS & FEATURES
MPR Weekly Dose Podcast #146
January 2023 Recap: Drug Pipeline Updates
Beta Blocker Use Tied to Reductions in Violence
Sleep Medication Used by 8.4% of Adults in 2020
Gepirone Under Review for Major Depressive Disorder
ACP Updates Clinical Guidelines for Major Depressive Disorder Treatment
Feds to Investigate Overuse of Antipsychotic Drugs by Nursing Homes
Frequent Green Space Visits Linked to Lower Use of Certain Meds
Rykindo Approved for Schizophrenia, Bipolar Disorder
Antipsychotics Increasingly Being Prescribed to Children
December 2022 Recap: Drug Pipeline Updates
Brexpiprazole Gets Priority Review for Agitation With Alzheimer Dementia
Phase 3 Trial Evaluating MDMA-Assisted Therapy for PTSD Meets Endpoints
Treatment-Resistant Depression Common and Costly
Iloperidone Benefits Patients With Bipolar I Disorder in Phase 3 Trial
Vraylar Approved as Adjunctive Therapy for Major Depressive Disorder
Intranasal Therapy for Major Depressive Disorder Gets Fast Track Status
Who Is Liable When Patient Fails to Get Required Blood Work Done?
